Former FDA chief raises alarm over GRAS in America's food

In an interview on '60 Minutes," Dr David Kessler warned foods considered "empty calories" have widespread impacts on health.

Top Republican eyeing FDA overhaul

Sen. Bill Cassidy (R-La.) on Tuesday unveiled his proposal for modernizing the Food and Drug Administration (FDA), calling on ...
Stocktwits on MSNOpinion

Anktiva vs Keytruda: ImmunityBio exec chair slams FDA for double standards in approvals

ImmunityBio Executive Chairman Patrick Soon-Shiong criticized the FDA for applying tougher approval standards to Anktiva than ...
The American Bazaar

FDA to reconsider ‘recognized as safe’ for ultra processed food

FDA to reconsider GRAS status of ultra processed foods, corn syrup, amid obesity and safety concerns raised by RFK Jr.
BioSpace

‘Just Agree to It:’ Pazdur Said He Was Told To Cosign FDA’s Reduced Trial Requirements

Richard Pazdur had spent 26 years at the FDA before stepping down last year due to disagreements with Commissioner Marty Makary about lowering the number of clinical trials required for a new drug ...
CURE

Expert Discusses FDA Approval of Chemo-Free Option for EGFR-Mutated Lung Cancer

The FDA has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneous, chemo-free ...

FDA blindsides Moderna with refusal to review flu vaccine application: ‘We’re pretty confused’

The Food and Drug Administration refused to review Moderna’s application for its new mRNA flu vaccine — a move the pharma ...
Fierce Pharma

FDA untitled letters target Novo’s 1st Wegovy pill ad and spots from argenx, Sobi

A batch of untitled letters posted on the FDA’s database in recent days takes aim at what the agency has termed “false or misleading” drug ads from the likes of Novo Nordisk, argenx and Sobi. | A ...
STAT

Moderna’s president weighs in on FDA’s decision not to review its flu vaccine

In an interview, Moderna President Stephen Hoge took questions on an FDA decision on the biotech's mRNA flu vaccine, as well as the impact on the company and others in the industry.